A powerful tuberculosis drug gets a deep price cut

Published on October 31, 2019

A powerful tuberculosis drug gets a deep price cut

By Jon Cohen

Sanofi, a pharmaceutical company based in Paris, announced today it will sell the drug rifapentine at the steeply discounted price. The full course of preventive treatment with the drug will drop from $45 to $15.

URL: https://www.sciencemag.org/news/2019/10/powerful-tuberculosis-drug-gets-deep-price-cut

Other news

WHO updates policy for the use of lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosing active tuberculosis in people living with HIV

October 31, 2019
WHO updates policy for the use of lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosing active tuberculosis in people living with HIVFollowing new evidence, WHO now recommends a broader use of urinary LAM assays for diagnosis of TB in people living with HIV.Link to policy: https://mailchi.mp/who/who_guidance_lf-lam_plhiv

New PPM Learning network to End TB launched at the Union World Conference on Lung Health

November 7, 2019
New PPM Learning network to End TB launched at the Union World Conference on Lung HealthQuality TB care for all people by all providers--World Health Organizationhttps://www.who.int/tb/features_archive/ppm-learning-network/en/